Interleukin-4 (IL-4) as a Marker of Atherosclerosis
Clinical trial NCT00256035 · WITHDRAWN
Trial details
- NCT number
- NCT00256035
- Sponsor
- Melbourne Health
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.